Business Wire

AGCO’s Beauvais Tractor Manufacturing Facility wins France’s Factory of the Year Award 2016

Del

AGCO, Your Agriculture Company (NYSE:AGCO), a worldwide manufacturer and distributor of agricultural equipment, is pleased to announce that its Tractor Manufacturing Facility in Beauvais, France has been presented with the country’s prestigious Factory of the Year 2016 award. The Beauvais site in Picardy beat ten other shortlisted factories from a wide range of industries in France to win the title.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160531006092/en/

(Photo: Business Wire)

(Photo: Business Wire)

The Factory of the Year Awards are organised by “L’Usine Nouvelle”, the leading industrial magazine in France. In selecting the overall Factory of the Year Award winner, the Jury looked for a facility which has demonstrated an in-depth transformation initiative and delivered significant performance gains including increases in productivity, quality, competitiveness and market share. A key partner of the awards event and a member of the judging panel is Boston Consulting Group, a leading global management and business strategy specialist.

The Beauvais facility is France’s largest producer and exporter of farm machinery. Some 14,500 tractors leave the assembly lines each year, 85% of which are shipped to markets all over the world.

The Factory of the Year award recognises the AGCO Beauvais facility’s successful and wide-ranging reorganisation project. The plant has seen significant productivity gains through the implementation of Lean Manufacturing processes, 5S good housekeeping techniques and the Hoshin Kanri Continuous Improvement Strategy. In addition, the Jury highlighted the site’s Quality Transformation Initiative and the clear commitment of Beauvais employees to the transformation process.

AGCO’s Beauvais facility is the centre for the design and manufacture of 75-400hp tractors for the Company’s global Massey Ferguson brand.

“It is a privilege and honour to win this coveted award,” says Richard Markwell, Vice President and Managing Director, Massey Ferguson, Europe, Africa, Middle East. “It is a tribute to our 2500-strong workforce at Beauvais who have been the architects of the factory’s major transformation over the last five years. This latest accolade is yet another milestone in our relentless pursuit of continuous improvement to ensure our customers get the very best products for their farm businesses.”

“The award comes in addition to the prize won by the Beauvais site earlier this year as France’s Best Foreign Exporter,” he continues. “High-quality manufacturing is at the heart of the renowned reliability and dependability of Massey Ferguson equipment. This, coupled with our leading design and engineering, is ensuring that our famous ‘Triple Triangle’ brand continues to move ahead. Massey Ferguson's market share increased again across the Europe, Africa, Middle East region last year – the 6th consecutive year we have increased this figure.”

Commenting, Boussad Bouaouli, Vice-President Manufacturing AGCO Beauvais says: “The Beauvais Quality Transformation Initiative is part of AGCO’s global objective to be N°1 in Perceived Quality and was considered an outstanding achievement by the Factory of the Year Award jury members. It illustrates every single employee’s dedication to deliver ‘best in class quality’ for each individual tractor on the production the line. We are thrilled to receive the title of Factory of the Year and congratulate all our employees in Beauvais. This award is truly the result of their commitment and hard work.”

Download pictures from http://assets.agcocorp.com

About AGCO

AGCO (NYSE: AGCO) is a global leader in the design, manufacture and distribution of agricultural solutions and supports more productive farming through its full line of equipment and related services. AGCO products are sold through five core brands, Challenger®, Fendt®, GSI®, Massey Ferguson® and Valtra®, supported by Fuse® precision technologies and farm optimization services, and are distributed globally through a combination of approximately 3,000 independent dealers and distributors in more than 140 countries. Founded in 1990, AGCO is headquartered in Duluth, GA, USA. In 2015, AGCO had net sales of $7.5 billion. For more information, visit http://www.AGCOcorp.com. For company news, information and events, please follow us on Twitter: @AGCOCorp. For financial news on Twitter, please follow the hashtag #AGCOIR.

Contact information

AGCO
Paul Lay, +44 (0)2476 851209
Manager, Marketing Communications and Public Relations
Mobile: 0044 7920805993
Paul.Lay@agcocorp.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom